The effect of myoinositol supplementation on the prevention of gestational diabetes mellitus
Phase 3
- Conditions
- Gestational diabetes mellitus (GDM).Gestational diabetes mellitusO24.4
- Registration Number
- IRCT20120826010664N4
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 276
Inclusion Criteria
BMI>30
Family history of type 2 diabetes
Previous history of GDM
Glucosoria
Glucose metabolism disorder
history of infant macrosomia
Exclusion Criteria
History of diabetes mellitus
Multiple pregnancy
Acute infection during pregnancy
Impaired GTT in first-trimester routine tests
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gestational diabetes mellitus. Timepoint: 24- 28 weeks of pregnancy. Method of measurement: glucose tolerance test.
- Secondary Outcome Measures
Name Time Method Type of delivery. Timepoint: end of pregnancy. Method of measurement: observational.;Macrosomia. Timepoint: After child birth. Method of measurement: observational.;Preterm labor. Timepoint: end of pregnancy. Method of measurement: observational.;Preeclampsia. Timepoint: end of pregnancy. Method of measurement: observational.;Premature rupture of membranes (PROM). Timepoint: end of pregnancy. Method of measurement: observational.;Intrauterine growth restriction (IUGR). Timepoint: end of pregnancy. Method of measurement: observational.